496915 Sigma-AldrichOridonin, R. rubescens - CAS 28957-04-2 - Calbiochem
A cell-permeable diterpenoid compound that possesses anti NF-κB activity and displays antiproliferative and antiangiogenic properties.
More>> A cell-permeable diterpenoid compound that possesses anti NF-κB activity and displays antiproliferative and antiangiogenic properties. Less<<Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
CAS # | Empirical Formula |
---|---|
28957-04-2 | C₂₀H₂₈O₆ |
Pricing & Availability
Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
---|---|---|---|---|---|---|
496915-5MG |
|
Plastic ampoule | 5 mg |
|
— |
References | |
---|---|
References | Ikezoe, T., et al. 2005. Mol. Cancer Ther. 4, 578. Meade-Tollin, L.C., et al. 2004. J. Nat. Prod. 67, 2. |
Product Information | |
---|---|
CAS number | 28957-04-2 |
ATP Competitive | N |
Form | Yellow solid |
Hill Formula | C₂₀H₂₈O₆ |
Chemical formula | C₂₀H₂₈O₆ |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | NF-κB transcriptional activity |
Primary Target IC<sub>50</sub> | 5 µg/ml inhibiting p65 NF-κB transcriptional activity in MT-1 cells |
Purity | ≥93% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS | |
---|---|
RTECS | NZ8177000 |
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
496915-5MG | 04055977199871 |
Documentation
Oridonin, R. rubescens - CAS 28957-04-2 - Calbiochem SDS
Title |
---|
Oridonin, R. rubescens - CAS 28957-04-2 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
496915 |
References
Reference overview |
---|
Ikezoe, T., et al. 2005. Mol. Cancer Ther. 4, 578. Meade-Tollin, L.C., et al. 2004. J. Nat. Prod. 67, 2. |